Neoprobe gets grant to further Lymphoseek development

11/3/2010 | MarketWatch

Neoprobe has received a nearly $250,000 grant from the qualifying therapeutic discovery project program, which was developed under the health reform law. "This cash award will provide additional support for the development of Lymphoseek, our lead program, without diluting the value of either our assets or our equity," President and CEO David C. Bupp said.

View Full Article in:

MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ